Voyager Therapeutics, Inc.
NASDAQVoyager Therapeutics reports today with one striking contradiction: the stock is up 10% over the past month, yet executives have been consistently selling into that strength. The insider signal is the standout here. The CEO, CFO, COO, and Chief Scientific Officer all sold shares in February, and the CEO sold again in early April at $3.87 — still well below the current $4.24. Net…
Snapshot as of 15 May 2026
Voyager Therapeutics reports today with one striking contradiction: the stock is up 10% over the past month, yet executives have been consistently selling into that strength. The insider signal is the standout here.…
VYGR enters today's Q1 2026 print with a contradictory setup: the stock fell 5% on Wednesday alone, yet options traders remain conspicuously calm, and the borrow market is about as relaxed as it gets. The most striking…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VYGR — free to start on ORTEX.
Sign up for free →Open VYGR on ORTEX